Mirador Global
Mirador Global specializes in strategic commercial activities to support early drug development and successful market entry, focusing on oncology and specialty care for complex conditions.
Services
Mirador Global offers comprehensive services to support early drug development and successful market penetration. Key services include global market access support, global commercial strategy development, data strategy across the commercial lifecycle, commercial roadmap and launch planning, portfolio assessment and prioritization, payer reimbursement risk assessment and mitigation, and US and global forecasting and asset valuation. The company engages early in clinical development to integrate payer, provider, and patient insights. They also offer solutions and tools to tackle difficult business questions and turn recommendations into actionable strategies.
Specialties and Sector Focus
Mirador Global specializes in oncology and specialty care, with expertise in rare diseases, immunology, neurology, and other complex conditions. The company focuses on strategic commercial activities to support early drug development and aims to facilitate successful go-to-market strategies in both US and ex-US markets. Mirador Global's methodology is distinguished by its early engagement in the clinical development process and its patient-centered epidemiological forecasting.
Data and Forecasting
Mirador Global provides rigorous and realistic forecasting for pre-launch pharmaceutical products. Their approach to pharmaceutical demand forecasting is designed to accurately and efficiently assess opportunities and challenges. They use a patient-centered epidemiological forecasting methodology and offer a service called FUEL to guide cross-functional launch teams for impactful market entry, ensuring strategic orchestration of commercial activities pivotal for early-stage drug development.
Location
Mirador Global is located at 106 Forest Drive, Kennett Square, PA 19348. From this location, they integrate with and supplement client teams, bringing real-world experience in global commercialization, market access, reimbursement, and pricing strategies. Their operations are designed to provide a seamless extension of client capabilities to ensure impactful results.
Strategic Goals
Mirador Global aims to be the 'go-to' ally for leading emerging commercialization strategy and tactical implementation by 2025. The company's strategic goals are centered around providing early engagement in clinical development, integrating payer, provider, and patient insights, and offering tools and solutions to tackle complex business questions. By bringing together cross-functional teams, including marketing, medical affairs, and R&D, they focus on strategic orchestration pivotal for early-stage drug development.